The store will not work correctly when cookies are disabled.
Pyrrolidine-1-carbothioic acid (1-pyrazin-2-yl-ethylidene)-hydrazide
ID: ALA221062
Cas Number: 85748-56-7
PubChem CID: 9579563
Max Phase: Preclinical
Molecular Formula: C11H15N5S
Molecular Weight: 249.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\NC(=S)N1CCCC1)c1cnccn1
Standard InChI: InChI=1S/C11H15N5S/c1-9(10-8-12-4-5-13-10)14-15-11(17)16-6-2-3-7-16/h4-5,8H,2-3,6-7H2,1H3,(H,15,17)/b14-9+
Standard InChI Key: VYYCUPFQSXZZSA-NTEUORMPSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
5.1527 -2.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1516 -2.8732 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8664 -3.2860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5828 -2.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5800 -2.0422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8646 -1.6330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2980 -3.2841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2992 -4.1091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0118 -2.8704 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7269 -3.2818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4407 -2.8682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1558 -3.2796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4394 -2.0432 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.2390 -4.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0463 -4.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4577 -3.5536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9046 -2.9415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 9 2 0
4 5 1 0
9 10 1 0
2 3 1 0
10 11 1 0
5 6 2 0
11 12 1 0
6 1 1 0
11 13 2 0
12 14 1 0
1 2 2 0
4 7 1 0
3 4 2 0
7 8 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.34 | Molecular Weight (Monoisotopic): 249.1048 | AlogP: 1.17 | #Rotatable Bonds: 2 |
Polar Surface Area: 53.41 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.78 | CX Basic pKa: 0.04 | CX LogP: 0.31 | CX LogD: 0.31 |
Aromatic Rings: 1 | Heavy Atoms: 17 | QED Weighted: 0.48 | Np Likeness Score: -1.96 |
References
1. Easmon J, Heinisch G, Holzer W, Rosenwirth B.. (1992) Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents., 35 (17): [PMID:1354751] [10.1021/jm00095a027] |
2. Kowol CR, Berger R, Eichinger R, Roller A, Jakupec MA, Schmidt PP, Arion VB, Keppler BK.. (2007) Gallium(III) and iron(III) complexes of alpha-N-heterocyclic thiosemicarbazones: synthesis, characterization, cytotoxicity, and interaction with ribonucleotide reductase., 50 (6): [PMID:17315858] [10.1021/jm0612618] |